Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.

    Mavigner M, Delobel P, Cazabat M, Dubois M, L'faqihi-Olive FE, Raymond S, Pasquier C, Marchou B, Massip P, Izopet J.

    PLoS One. 2009 Oct 30;4(10):e7658.PMID: 19876401 [PubMed - in process]Related articlesFree article

    2.

    Determining seminal plasma human immunodeficiency virus type 1 load in the context of efficient highly active antiretroviral therapy.

    Pasquier C, Sauné K, Raymond S, Moinard N, Daudin M, Bujan L, Izopet J.

    J Clin Microbiol. 2009 Sep;47(9):2883-7. Epub 2009 Jul 29.PMID: 19641060 [PubMed - indexed for MEDLINE]Related articles

    3.

    Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism.

    Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Encinas S, Sandres-Sauné K, Pasquier C, Marchou B, Massip P, Izopet J.

    J Clin Microbiol. 2009 Jul;47(7):2292-4. Epub 2009 May 13.PMID: 19439544 [PubMed - indexed for MEDLINE]Related articles

    4.

    Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.

    Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Sandres-Sauné K, Cuzin L, Marchou B, Massip P, Izopet J.

    AIDS. 2008 Sep 12;22(14):F11-6.PMID: 18753930 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...